Compare ARK Genomic Revolution ETF (ARKG) vs iShares China Large-Cap ETF (FXI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares China Large-Cap ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while iShares China Large-Cap ETF trades at $33.45. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | FXI | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $41.75 |
52-Week Low | $23.09 | $31.59 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FXI trades at $33.48, up 0.21% on the day, with a bullish technical signal from moving averages but neutral oscillators. The ETF shows mixed momentum with RSI_6 at 89.10 indicating overbought conditions. Recent news highlights China's push in AI and EVs, with a $295 billion AI infrastructure plan and a 30% NEV fleet target by 2030, potentially benefiting FXI's holdings. Support sits at $33, resistance at $34.
Outlook is cautiously optimistic due to China's tech and manufacturing rebound, though risks include U.S.-China tensions and valuation concerns. The ETF lacks current fundamental ratios, but sector growth offers upside if geopolitical and regulatory pressures ease.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →
